NEW YORK (GenomeWeb News) – Exact Sciences today said that revenues in the fourth quarter were flat year over year, while its net loss widened.

The Madison, Wis.-based firm recorded $1.0 million in revenues for the three months ended Dec. 31, 2012, the same as a year ago and even with the average Wall Street estimate. All revenues came from licensing fees in the recently completed quarter, and the company had no product royalty fees, compared to $6,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.